POTASSIUM O-PHENYLPHENATE

RestrictedCAS 13707-65-811 regulations across 10 markets

POTASSIUM O-PHENYLPHENATE is a cosmetic ingredient classified as Antimicrobial. Also known as CAS 13707-65-8. It is regulated in 10 markets including UAE, Bahrain, European Union.

Also Known As

CAS Number
132-27-4, 13707-65-8, 90-43-7

Market Overview — 29 Markets

European Union1
United Kingdom2
United States
California
Maryland
Washington
Canada
Brazil
South Korea1
Japan
Taiwan1
Australia
Singapore
Malaysia
Thailand
Indonesia
Vietnam
Philippines
UAE1
Saudi Arabia1
Qatar1
Oman1
Kuwait1
Bahrain1
Russia
Belarus
Kazakhstan
Armenia
Kyrgyzstan

Detailed Regulations

Europe3 regulations
European UnionRestrictedAnnex V #7
Chemical name
Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl, Sodium 2-biphenylate
CAS
90-43-7, 132-27-4
Max concentration
(a) 0,2 % (as phenol (b) 0,15 % (as phenol)
Product type
(a) Rinse-off products (b) Leave-on products
Conditions of use
Avoid contact with eyes.
Other conditions
When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products.

Source: EC 1223/2009 Annex V

United KingdomRestrictedAnnex V #7
Chemical name
Biphenyl-2-ol
CAS
90-43-7
Max concentration
(a) 0,2 % (as phenol)
Product type
(a) Rinse-off Products
Conditions of use
Max: (a) 0,2 % (as phenol) Avoid contact with eyes

Source: UK retained EC 1223/2009 Annex V

United KingdomRestrictedAnnex V #7
Chemical name
Biphenyl-2-ol
CAS
90-43-7
Max concentration
(b) 0,15 % (as phenol)
Product type
(b) Leave-on products
Conditions of use
Max: (b) 0,15 % (as phenol) Avoid contact with eyes

Source: UK retained EC 1223/2009 Annex V

AmericasNo restrictions

No specific restrictions for POTASSIUM O-PHENYLPHENATE in United States, California, Maryland, Washington, Canada, Brazil.

East Asia & Oceania2 regulations
South KoreaRestrictedAnnex restricted #M1316
Chemical name
Potassium o-Phenylphenate
Conditions of use
* 배합한도 : 페놀로서 0.15%

Source: MFDS Korea Cosmetics Regulation

TaiwanRestrictedAnnex Preservatives List #31
Chemical name
Biphenyl-2-ol, and its salts
CAS
90-43-7/ 132-27-4/ 84145-04-0/ 13707-65-8
Max concentration
0.2 % (以phenol計)

Source: TFDA Cosmetics Regulations

ASEANNo restrictions

No specific restrictions for POTASSIUM O-PHENYLPHENATE in Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines.

GCC6 regulations
UAERestrictedAnnex V #7
Chemical name
Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl, Sodium 2-biphenylate
CAS
90-43-7, 132-27-4
Max concentration
(a) 0,2 % (as phenol (b) 0,15 % (as phenol)
Product type
(a) Rinse-off products (b) Leave-on products
Conditions of use
Avoid contact with eyes.
Other conditions
When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products.

Source: GSO 1943:2024 (based on EU 1223/2009 V)

Saudi ArabiaRestrictedAnnex V #7
Chemical name
Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl, Sodium 2-biphenylate
CAS
90-43-7, 132-27-4
Max concentration
(a) 0,2 % (as phenol (b) 0,15 % (as phenol)
Product type
(a) Rinse-off products (b) Leave-on products
Conditions of use
Avoid contact with eyes.
Other conditions
When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products.

Source: GSO 1943:2024 (based on EU 1223/2009 V)

QatarRestrictedAnnex V #7
Chemical name
Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl, Sodium 2-biphenylate
CAS
90-43-7, 132-27-4
Max concentration
(a) 0,2 % (as phenol (b) 0,15 % (as phenol)
Product type
(a) Rinse-off products (b) Leave-on products
Conditions of use
Avoid contact with eyes.
Other conditions
When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products.

Source: GSO 1943:2024 (based on EU 1223/2009 V)

OmanRestrictedAnnex V #7
Chemical name
Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl, Sodium 2-biphenylate
CAS
90-43-7, 132-27-4
Max concentration
(a) 0,2 % (as phenol (b) 0,15 % (as phenol)
Product type
(a) Rinse-off products (b) Leave-on products
Conditions of use
Avoid contact with eyes.
Other conditions
When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products.

Source: GSO 1943:2024 (based on EU 1223/2009 V)

KuwaitRestrictedAnnex V #7
Chemical name
Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl, Sodium 2-biphenylate
CAS
90-43-7, 132-27-4
Max concentration
(a) 0,2 % (as phenol (b) 0,15 % (as phenol)
Product type
(a) Rinse-off products (b) Leave-on products
Conditions of use
Avoid contact with eyes.
Other conditions
When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products.

Source: GSO 1943:2024 (based on EU 1223/2009 V)

BahrainRestrictedAnnex V #7
Chemical name
Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl, Sodium 2-biphenylate
CAS
90-43-7, 132-27-4
Max concentration
(a) 0,2 % (as phenol (b) 0,15 % (as phenol)
Product type
(a) Rinse-off products (b) Leave-on products
Conditions of use
Avoid contact with eyes.
Other conditions
When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products.

Source: GSO 1943:2024 (based on EU 1223/2009 V)

EAEUNo restrictions

No specific restrictions for POTASSIUM O-PHENYLPHENATE in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.

Frequently Asked Questions

Is POTASSIUM O-PHENYLPHENATE banned in any country?

POTASSIUM O-PHENYLPHENATE is not banned in any of the 26 markets tracked by Formpli. However, it may be subject to restrictions or conditions of use in some markets.

What are the restrictions on POTASSIUM O-PHENYLPHENATE in cosmetics?

POTASSIUM O-PHENYLPHENATE is restricted or has conditions of use in UAE, Bahrain, European Union, South Korea, Kuwait, Oman, Qatar, Saudi Arabia, Taiwan, United Kingdom. Restrictions may include maximum concentration limits, product type limitations, or mandatory labeling requirements. See the detailed regulations above for specifics.

Can I use POTASSIUM O-PHENYLPHENATE in cosmetics?

POTASSIUM O-PHENYLPHENATE is regulated in 10 markets. It has restrictions in UAE, Bahrain, European Union, South Korea, Kuwait, Oman, Qatar, Saudi Arabia, Taiwan, United Kingdom. Use Formpli's free screening tool to check your full ingredient list against all 26 markets at once.

Screen POTASSIUM O-PHENYLPHENATE with your full formula

Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.

Check Ingredients Free

This information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.